Ontology type: schema:ScholarlyArticle Open Access: True
2015-04-18
AUTHORSIsaac Melguizo-Gavilanes, Janet M. Bruner, Nandita Guha-Thakurta, Kenneth R. Hess, Vinay K. Puduvalli
ABSTRACTPseudoprogression (psPD) refers to an increase in size or appearance of new areas of MRI contrast enhancement soon after completing chemoradiation, timely diagnosis of which has been a challenge. Given that tissue sampling of the MRI changes would be expected to accurately distinguish psPD from true progression when MRI changes are first seen, we examined the utility of surgery in diagnosing psPD and influencing patient outcome. We retrospectively reviewed data from adults with GBM who had MRI changes suggestive of progression within 3 months of chemoRT; of these, 34 underwent surgical resection. Three subsets–tumor, psPD or mixed-were identified based on histology and immunohistochemistry in the surgical group and by imaging characteristics in the nonsurgical group. A cohort of patients with stable disease post-chemoRT served as control. PFS and OS were determined using the Kaplan–Meier method and log rank analysis. Concordance for psPD between radiological interpretation and subsequent histological diagnosis was seen in only 32 % of cases (11/34) 95 %CI 19–49 %. A large proportion of patients had a histologically “mixed” pattern with tumor and treatment effect. No significant differences in PFS or OS were seen among the three subtypes. Surgical sampling and histologic review of MRI changes after chemoRT may not serve as a gold standard to distinguish psPD from true progression in GBM patients. Refinement of the histological criteria, careful intraoperative selection of regions of interest and advanced imaging modalities are needed for early differentiation of PsPD from progression to guide clinical management. More... »
PAGES141-150
http://scigraph.springernature.com/pub.10.1007/s11060-015-1774-5
DOIhttp://dx.doi.org/10.1007/s11060-015-1774-5
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1018898395
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/25894594
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomarkers, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Brain Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Chemoradiotherapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease Progression",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Follow-Up Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glioblastoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Immunoenzyme Techniques",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Magnetic Resonance Imaging",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Staging",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prognosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Survival Rate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Young Adult",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Neuro-Oncology Associates at Baylor Charles A. Sammons Cancer Center, 75246, Dallas, TX, USA",
"id": "http://www.grid.ac/institutes/grid.486749.0",
"name": [
"Neuro-Oncology Associates at Baylor Charles A. Sammons Cancer Center, 75246, Dallas, TX, USA"
],
"type": "Organization"
},
"familyName": "Melguizo-Gavilanes",
"givenName": "Isaac",
"id": "sg:person.01013322710.32",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013322710.32"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Bruner",
"givenName": "Janet M.",
"id": "sg:person.013375073077.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013375073077.30"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Guha-Thakurta",
"givenName": "Nandita",
"id": "sg:person.01071535250.43",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071535250.43"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Hess",
"givenName": "Kenneth R.",
"id": "sg:person.010260560177.95",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010260560177.95"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Neuro-oncology, The Ohio State University Comprehensive Cancer Center, 320 W, 10th Ave, M410 Staling Loving Hall, 43210, Columbus, OH, USA",
"id": "http://www.grid.ac/institutes/grid.261331.4",
"name": [
"Division of Neuro-oncology, The Ohio State University Comprehensive Cancer Center, 320 W, 10th Ave, M410 Staling Loving Hall, 43210, Columbus, OH, USA"
],
"type": "Organization"
},
"familyName": "Puduvalli",
"givenName": "Vinay K.",
"id": "sg:person.01156403355.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156403355.42"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s11910-009-0035-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052174107",
"https://doi.org/10.1007/s11910-009-0035-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-006-9241-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015983460",
"https://doi.org/10.1007/s11060-006-9241-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-009-9897-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030107392",
"https://doi.org/10.1007/s11060-009-9897-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10014-012-0109-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012468803",
"https://doi.org/10.1007/s10014-012-0109-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-009-9809-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004320007",
"https://doi.org/10.1007/s11060-009-9809-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00401-005-0023-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019017045",
"https://doi.org/10.1007/s00401-005-0023-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-005-5262-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031267961",
"https://doi.org/10.1007/s11060-005-5262-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-007-9341-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000374634",
"https://doi.org/10.1007/s11060-007-9341-3"
],
"type": "CreativeWork"
}
],
"datePublished": "2015-04-18",
"datePublishedReg": "2015-04-18",
"description": "Abstract\n\nPseudoprogression (psPD) refers to an increase in size or appearance of new areas of MRI contrast enhancement soon after completing chemoradiation, timely diagnosis of which has been a challenge. Given that tissue sampling of the MRI changes would be expected to accurately distinguish psPD from true progression when MRI changes are first seen, we examined the utility of surgery in diagnosing psPD and influencing patient outcome. We retrospectively reviewed data from adults with GBM who had MRI changes suggestive of progression within 3\u00a0months of chemoRT; of these, 34 underwent surgical resection. Three subsets\u2013tumor, psPD or mixed-were identified based on histology and immunohistochemistry in the surgical group and by imaging characteristics in the nonsurgical group. A cohort of patients with stable disease post-chemoRT served as control. PFS and OS were determined using the Kaplan\u2013Meier method and log rank analysis. Concordance for psPD between radiological interpretation and subsequent histological diagnosis was seen in only 32\u00a0% of cases (11/34) 95\u00a0%CI 19\u201349\u00a0%. A large proportion of patients had a histologically \u201cmixed\u201d pattern with tumor and treatment effect. No significant differences in PFS or OS were seen among the three subtypes. Surgical sampling and histologic review of MRI changes after chemoRT may not serve as a gold standard to distinguish psPD from true progression in GBM patients. Refinement of the histological criteria, careful intraoperative selection of regions of interest and advanced imaging modalities are needed for early differentiation of PsPD from progression to guide clinical management.",
"genre": "article",
"id": "sg:pub.10.1007/s11060-015-1774-5",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2438826",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2420949",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1094205",
"issn": [
"0167-594X",
"1573-7373"
],
"name": "Journal of Neuro-Oncology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "123"
}
],
"keywords": [
"MRI changes",
"true progression",
"utility of surgery",
"cohort of patients",
"Kaplan-Meier method",
"log-rank analysis",
"gold standard",
"subsequent histological diagnosis",
"advanced imaging modalities",
"nonsurgical group",
"surgical resection",
"surgical group",
"histological diagnosis",
"histologic review",
"surgical sampling",
"clinical management",
"patient outcomes",
"timely diagnosis",
"histological criteria",
"GBM patients",
"patients",
"intraoperative selection",
"radiological interpretation",
"progression",
"imaging modalities",
"chemoRT",
"treatment effects",
"pseudoprogression",
"significant differences",
"MRI contrast enhancement",
"PSPD",
"PFS",
"contrast enhancement",
"histology",
"diagnosis",
"cases 95",
"rank analysis",
"early differentiation",
"large proportion",
"chemoradiation",
"resection",
"OS",
"surgery",
"group",
"immunohistochemistry",
"cohort",
"tumors",
"subtypes",
"cis-19",
"glioblastoma",
"months",
"outcomes",
"adults",
"GBM",
"modalities",
"changes",
"tissue",
"concordance",
"review",
"proportion",
"differentiation",
"management",
"differences",
"control",
"criteria",
"appearance",
"increase",
"standards",
"effect",
"utility",
"patterns",
"data",
"sampling",
"new areas",
"analysis",
"area",
"challenges",
"characteristics",
"enhancement",
"region",
"Abstract",
"size",
"selection",
"method",
"interest",
"characterization",
"interpretation",
"refinement",
"months of chemoRT",
"stable disease post-chemoRT",
"disease post-chemoRT",
"post-chemoRT",
"careful intraoperative selection",
"Characterization of pseudoprogression"
],
"name": "Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?",
"pagination": "141-150",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1018898395"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s11060-015-1774-5"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"25894594"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s11060-015-1774-5",
"https://app.dimensions.ai/details/publication/pub.1018898395"
],
"sdDataset": "articles",
"sdDatePublished": "2022-01-01T18:36",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_662.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s11060-015-1774-5"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1774-5'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1774-5'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1774-5'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1774-5'
This table displays all metadata directly associated to this object as RDF triples.
306 TRIPLES
22 PREDICATES
147 URIs
131 LITERALS
26 BLANK NODES